Over a week ago |
Hot Stocks
|
Leidos announced that the… Leidos announced that the Defense Enclave Services contract awarded by the Defense Information Systems Agency was upheld by the Government Accountability Office after a thorough and disciplined review. The single-award, indefinite delivery, indefinite quantity contract was initially awarded in February 2022 and holds a total estimated value of $11.5B if all options are exercised. It includes a four-year base period of performance followed by three two-year option periods. ShowHide Related Items >><< - 06/16/22
- Leidos selected by Punta Cana Airport to upgrade security checkpoints
- 05/31/22
- Leidos unit awarded two prime contracts worth up to $1.7B
- 05/06/22
- Leidos awarded $90M in NATO ballistic missile defense contracts
- 04/06/22
- Nauticus Robotics appoints Donnelly Bohan as COO
- 06/07/22 Barclays
- Leidos downgraded to Equal Weight from Overweight at Barclays
- 05/04/22 Truist
- Leidos price target raised to $120 from $108 at Truist
- 04/13/22 Goldman Sachs
- CACI downgraded to Neutral from Buy at Goldman Sachs
- 03/24/22 Wells Fargo
- Wells Fargo downgrades Leidos to Equal Weight, raises price target to $113
- 05/03/22
- Leidos backs FY22 EPS view $6.10-$6.50, consensus $6.50
- 05/03/22
- Leidos reports Q1 EPS $1.58, consensus $1.50
- 02/15/22
- Leidos sees FY22 EPS $6.10-$6.50, consensus $6.85
- 02/15/22
- Leidos reports Q4 EPS $1.56, consensus $1.60
- 03/10/22
- ManTech drawing interest from Veritas, Leidos, Dealreporter says
- 03/24/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/15/22
- What You Missed On Wall Street On Tuesday
- 02/15/22
- What You Missed On Wall Street This Morning
|
Hot Stocks
|
KBR announced that its… KBR announced that its SOCAR-KBR joint venture has been awarded a front-end engineering design, turnaround engineering, and procurement support services contract by BP Exploration for the Shah Deniz Alpha platform in Azerbaijan. This project will significantly reduce SDA's overall carbon footprint and increase operational efficiency, providing a robust, long-term, high-availability power supply. SOCAR-KBR will be responsible for the FEED services for decommissioning the existing five main power generators on the SDA platform. They will then create a power supply from the KBR-designed Shah Deniz Bravo platform through subsea cables and a back-up power generator. This project will be delivered from SOCAR-KBR's Baku office to maximize local execution, with specialist subject matter expert support provided from KBR's London operations. ShowHide Related Items >><< - 06/15/22
- KBR to acquire VIMA Group, terms undisclosed
- 06/01/22
- KBR to invest additional $100M in Mura Technology
- 05/24/22
- KBR rises 5.2%
- 05/23/22
- KBR awarded $44M Air Force contract
- 04/14/22 KeyBanc
- KBR price target raised to $66 from $55 at KeyBanc
- 03/17/22 Stifel
- KBR resumed with a Buy at Stifel
- 03/11/22 Truist
- KBR price target raised to $64 from $57 at Truist
- 03/04/22 DA Davidson
- DA Davidson upgrades KBR to Buy as geopolitics boosts defense contractors
- 04/28/22
- KBR raises FY22 adjusted EPS view to $2.53-$2.65 from $2.45-$2.60
- 04/28/22
- KBR reports Q1 adjusted EPS 62c, consensus 57c
- 02/22/22
- KBR sees FY22 adjusted EPS $2.45-$2.60, consensus $2.51
- 02/22/22
- KBR reports Q4 adjusted EPS 69c, consensus 65c
|
Hot Stocks
|
Leidos was selected by… Leidos was selected by the Dominican Republic's Punta Cana International Airport, or PUJ, to upgrade their security checkpoints. The airport will utilize Leidos' technologies to keep passengers and staff safe while enhancing operational efficiencies and increasing passenger throughput. ShowHide Related Items >><< - 05/31/22
- Leidos unit awarded two prime contracts worth up to $1.7B
- 05/06/22
- Leidos awarded $90M in NATO ballistic missile defense contracts
- 04/06/22
- Nauticus Robotics appoints Donnelly Bohan as COO
- 03/17/22
- Leidos awarded $84M prime contract by U.S Navy's NAVWAR
- 06/07/22 Barclays
- Leidos downgraded to Equal Weight from Overweight at Barclays
- 05/04/22 Truist
- Leidos price target raised to $120 from $108 at Truist
- 04/13/22 Goldman Sachs
- CACI downgraded to Neutral from Buy at Goldman Sachs
- 03/24/22 Wells Fargo
- Wells Fargo downgrades Leidos to Equal Weight, raises price target to $113
- 05/03/22
- Leidos backs FY22 EPS view $6.10-$6.50, consensus $6.50
- 05/03/22
- Leidos reports Q1 EPS $1.58, consensus $1.50
- 02/15/22
- Leidos sees FY22 EPS $6.10-$6.50, consensus $6.85
- 02/15/22
- Leidos reports Q4 EPS $1.56, consensus $1.60
- 03/10/22
- ManTech drawing interest from Veritas, Leidos, Dealreporter says
- 03/24/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/18/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/15/22
- What You Missed On Wall Street On Tuesday
- 02/15/22
- What You Missed On Wall Street This Morning
|
Hot Stocks
|
KBR announced it has… KBR announced it has entered into a definitive agreement to acquire U.K.-based VIMA Group, a provider of digital transformation solutions to defense and other public sector clients, for up to GBP 75M, inclusive of earn-out opportunities. VIMA Group delivers solutions across a number of large-scale, high priority digital transformation programs to support its clients in ensuring availability of effective digital and information technology as guided by the U.K.'s Digital Strategy for Defence. ShowHide Related Items >><< - 06/01/22
- KBR to invest additional $100M in Mura Technology
- 05/24/22
- KBR rises 5.2%
- 05/23/22
- KBR awarded $44M Air Force contract
- 05/16/22
- Raytheon Intelligence & Space, Kord partner to defeat multiple mortars
- 04/14/22 KeyBanc
- KBR price target raised to $66 from $55 at KeyBanc
- 03/17/22 Stifel
- KBR resumed with a Buy at Stifel
- 03/11/22 Truist
- KBR price target raised to $64 from $57 at Truist
- 03/04/22 DA Davidson
- DA Davidson upgrades KBR to Buy as geopolitics boosts defense contractors
- 04/28/22
- KBR raises FY22 adjusted EPS view to $2.53-$2.65 from $2.45-$2.60
- 04/28/22
- KBR reports Q1 adjusted EPS 62c, consensus 57c
- 02/22/22
- KBR sees FY22 adjusted EPS $2.45-$2.60, consensus $2.51
- 02/22/22
- KBR reports Q4 adjusted EPS 69c, consensus 65c
|
Recommendations
|
Cowen analyst Cai von… Cowen analyst Cai von Rumohr lowered the firm's price target on Booz Allen to $103 from $109 and keeps an Outperform rating on the shares. The analyst called it a "pure play" defense IT leader and said it is positioned for the sector's fastest organic growth in 2023 after two years of lagging peers. He said key drivers are robust booking prospects and an improving net hiring environment as the economy slows. ShowHide Related Items >><< - 06/07/22
- Booz Allen awarded NASA CyPrESS contract
- 05/20/22
- Booz Allen appoints Kristine Martin Anderson as COO
- 05/20/22
- Booz Allen sees FY23 net cash from operating activities $850M-$950M
- 05/17/22
- Booz Allen awarded $622.5M CyPrESS contract from NASA
- 06/07/22 Barclays
- Booz Allen downgraded to Equal Weight from Overweight at Barclays
- 05/25/22 Raymond James
- Booz Allen price target raised to $96 from $90 at Raymond James
- 05/18/22 William Blair
- William Blair cautious on Booz Allen shares into Friday's earnings
- 04/13/22 Goldman Sachs
- CACI downgraded to Neutral from Buy at Goldman Sachs
- 05/20/22
- Booz Allen sees FY23 adjusted EPS $4.15-$4.45, consensus $4.56
- 05/20/22
- Booz Allen reports Q4 adjusted EPS 86c, consensus 87c
- 05/19/22
- Notable companies reporting before tomorrow's open
- 06/07/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/20/22
- What You Missed On Wall Street On Friday
- 05/20/22
- What You Missed On Wall Street This Morning
- 04/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|
On The Fly
| ShowHide Related Items >><< - 05/25/22
- Exxon Mobil says focused on five priorities to grow shareholder value
- 05/19/22
- Exxon Mobil to sell Barnett Shale assets to BKV for $750M
- 05/16/22
- Paulson exits Cerner, boosts Didi in Q1
- 05/03/22
- Exxon Mobil to sell Romanian affiliate to Romgaz for more than $1B
- 05/31/22
- TherapeuticsMD signs definitive agreement to be accquired by affiliate of EW
- 05/20/22
- TherapeuticsMD receives FDA approval for sNDA for ANNOVERA
- 05/09/22
- TherapeuticsMD trading resumes
- 05/09/22
- TherapeuticsMD trading halted, volatility trading pause
- 03/31/22
- Science 37 appoints Shaalan Beg to Global Management Team
- 03/01/22
- Science 37 publishes CNS therapeutic data from CNS survey
- 02/24/22
- Science 37's Operating System receives ISO certification
- 02/17/22
- Science 37 says provider network grows sixfold in 2021
- 05/05/22
- RLI Corp. raises quarterly dividend to 26c from 25c per share
- 03/14/22
- RLI Corp. sells minority interest in Maui Jim for $500M
PRAX Praxis Precision Medicines - 06/06/22
- Praxis Precision Medicines down 65% after Aria Study misses goal
- 06/06/22
- Praxis Precision Medicines trading resumes
- 06/06/22
- Praxis Precision Medicines sees cash runway into 2024
- 06/06/22
- Praxis to prioritize programs in movement disorders, epilepsy
- 01/26/22
- Plexus reports Q1 EPS 82c, consensus $1.12
- 06/07/22
- 1PointFive, Carbon Engineering announce direct air capture deployment approach
- 05/23/22
- Occidental Petroleum announces tender results, upsize of cash tender offers
- 05/16/22
- Berkshire Hathaway adds Citi, exits Wells Fargo in Q1
- 06/06/22
- Mirati Therapeutics announces results from Phase 1b cohort of KRYSTAL-1
- 05/27/22
- Mirati Therapeutics trading resumes
- 05/27/22
- Mirati Therapeutics trading halted, volatility trading pause
- 05/26/22
- Mirati Therapeutics says disease control rate was 80% in study
- 05/31/22
- McKesson CFO sells $9.1M in common stock
- 05/03/22
- Distributors agree to $518M opioid settlement With Washington state
- 02/25/22
- AmerisourceBergen, Cardinal Health and McKesson approve opioid settlement pact
- 12/22/21
- Distributors announce extension of opioid settlement sign-on period
- 05/20/22
- Lear to acquire I.G. Bauerhin for EUR 140M on a cash-and debt-free basis
- 05/19/22
- Lear extends share repurchase plan for two years
- 05/19/22
- Lear acquires Thagora Technology, terms not disclosed
- 03/14/22
- Shyft Group appoints Esposito to board of directors
- 06/01/22
- GXO Logistics opens new pharmaceutical warehouse in Milan
- 05/24/22
- GXO Logistics completes cash, share offer for Clipper Logistics
- 05/16/22
- GXO Logistics partners with Sente Foundry to accelerate logistics innovation
- 05/04/22
- GXO Logistics CEO: Consumers are confident
- 05/06/22
- GrafTech says 'overall fundamentals in the steel industry are strong'
- 02/28/22
- GrafTech CEO David Rintoul announces intent to retire
- 02/04/22
- GrafTech sees itself well positioned in FY22
- 05/19/22
- Matterhorn Express pipeline reaches final investment decision
- 05/16/22
- Soros Capital buys Suncor and Mosaic during Q1, exits Alphabet
- 05/02/22
- Devon increases quarterly dividend to $1.27, expands share repurchase program
- 05/02/22
- Devon Energy sees FY22 production 570-600 mboepd
- 06/07/22
- Booz Allen awarded NASA CyPrESS contract
- 05/20/22
- Booz Allen appoints Kristine Martin Anderson as COO
- 05/20/22
- Booz Allen sees FY23 net cash from operating activities $850M-$950M
- 05/17/22
- Booz Allen awarded $622.5M CyPrESS contract from NASA
- 06/02/22
- Alnylam: C16-siRNA led to potent, durable knockdown in CNS, behavioral deficits
- 06/01/22
- ProQR Therapeutics provides leadership updates
- 05/24/22
- Alnylam presents data from ILLUMINATE study of lumasiran on reduction of POx
- 05/23/22
- Alnylam announces new results from 18-month analysis of HELIOS-A study
- 06/07/22 Raymond James
- Plexus upgraded to Outperform from Market Perform at Raymond James
- 01/28/22 Needham
- Plexus price target lowered to $90 from $95 at Needham
- 08/23/21 Fox Advisors
- Plexus upgraded to Overweight from Equal Weight at Fox Advisors
- 06/22/21 Sidoti
- Plexus upgraded to Buy from Neutral at Sidoti
- 06/07/22 Seaport Global
- ProFrac Holding initiated with a Buy at Seaport Global
- 06/07/22 Piper Sandler
- ProFrac Holding initiated with an Overweight at Piper Sandler
- 06/07/22 JPMorgan
- ProFrac Holding initiated with an Overweight at JPMorgan
- 06/07/22 Stifel
- ProFrac Holding initiated with a Buy at Stifel
- 06/07/22 Raymond James
- RLI Corp. initiated with a Market Perform at Raymond James
- 04/22/22 RBC Capital
- RLI Corp. price target raised to $123 from $112 at RBC Capital
- 03/14/22 Keefe Bruyette
- Keefe Bruyette sees special dividend following RLI stake sale
- 02/22/22 Compass Point
- RLI Corp. upgraded to Buy at Compass Point after recent weakness
- 06/07/22 Stifel
- Mirati Therapeutics price target raised to $111 from $105 at Stifel
- 06/07/22 JMP Securities
- Mirati Therapeutics upgraded to Outperform from Market Perform at JMP Securities
- 05/27/22 Stifel
- Mirati Therapeutics after-hours move lower 'overdone,' says Stifel
- 05/20/22 Guggenheim
- Guggenheim upgrades Mirati to Buy on adagrasib's 'highly competitive profile'
- 06/07/22 Wells Fargo
- Wells Fargo upgrades Lear on valuation, electric vehicle 'optionality'
- 06/07/22 Wells Fargo
- Lear upgraded to Overweight from Equal Weight at Wells Fargo
- 06/01/22 Goldman Sachs
- Lear price target lowered to $158 from $163 at Goldman Sachs
- 06/01/22 Morgan Stanley
- Lear price target lowered to $144 from $160 at Morgan Stanley
- 06/07/22 Evercore ISI
- Evercore upgrades Exxon Mobil, sees 'achievable' path to doubling earnings
- 06/07/22 Credit Suisse
- Exxon Mobil price target raised to $115 from $102 at Credit Suisse
- 06/07/22 Evercore ISI
- Exxon Mobil upgraded to Outperform from In Line at Evercore ISI
- 06/03/22 JPMorgan
- Exxon Mobil share rally 'still has room,' says JPMorgan
- 06/07/22 William Blair
- Alnylam initiated with an Outperform at William Blair
- 05/02/22 H.C. Wainwright
- Alnylam price target raised to $430 from $400 at H.C. Wainwright
- 04/29/22 Citi
- Alnylam price target lowered to $211 from $223 at Citi
- 04/25/22 Morgan Stanley
- Alnylam downgraded to Equal Weight from Overweight at Morgan Stanley
- 06/07/22 Craig-Hallum
- Science 37 initiated with a Buy at Craig-Hallum
- 11/16/21 Lake Street
- Science 37 price target raised to $20 from $15 at Lake Street
- 11/01/21 Lake Street
- Lake Street starts Science 37 at Buy, says digitized trials 'here to stay'
- 11/01/21 Lake Street
- Science 37 initiated with a Buy at Lake Street
- 06/07/22 Barclays
- GXO Logistics reinstated with an Equal Weight at Barclays
- 06/06/22 Cowen
- GXO Logistics initiated with an Outperform at Cowen
- 05/09/22 Oppenheimer
- GXO Logistics price target lowered to $91 from $108 at Oppenheimer
- 04/20/22 Citi
- GXO Logistics price target lowered to $90 from $110 at Citi
- 06/07/22 Evercore ISI
- Evercore 'taking some chips off the table,' downgrades Devon Energy to In Line
- 06/07/22 Evercore ISI
- Occidental Petroleum downgraded to In Line from Outperform at Evercore ISI
- 05/31/22 Mizuho
- Occidental Petroleum price target raised to $89 from $85 at Mizuho
- 05/12/22 Wells Fargo
- Occidental Petroleum price target raised to $58 from $51 at Wells Fargo
- 06/07/22 Barclays
- Booz Allen downgraded to Equal Weight from Overweight at Barclays
- 05/25/22 Raymond James
- Booz Allen price target raised to $96 from $90 at Raymond James
- 05/18/22 William Blair
- William Blair cautious on Booz Allen shares into Friday's earnings
- 04/13/22 Goldman Sachs
- CACI downgraded to Neutral from Buy at Goldman Sachs
- 06/07/22 Citi
- GrafTech downgraded to Neutral at Citi on lack of near-term catalysts
- 06/07/22 Citi
- GrafTech downgraded to Neutral from Buy at Citi
- 05/17/22 GLJ Research
- GrafTech price target lowered to $4.93 from $6.72 at GLJ Research
- 08/10/21 RBC Capital
- GrafTech price target lowered to $14 from $16 at RBC Capital
- 06/07/22 Evercore ISI
- Devon Energy downgraded to In Line from Outperform at Evercore ISI
- 05/31/22 Mizuho
- Devon Energy price target raised to $92 from $89 at Mizuho
- 05/25/22 Barclays
- Devon Energy downgraded to Equal Weight from Overweight at Barclays
PRAX Praxis Precision Medicines - 06/07/22 BofA
- Praxis Precision Medicines downgraded to Neutral from Buy at BofA
- 06/07/22 H.C. Wainwright
- Praxis Precision price target lowered to $10 from $48 at H.C. Wainwright
- 06/06/22 Wedbush
- Wedbush downgrades Praxis to Neutral, slashes target after ARIA trial failure
- 06/06/22 Wedbush
- Praxis Precision Medicines downgraded to Neutral from Outperform at Wedbush
- 06/07/22 H.C. Wainwright
- TherapeuticsMD downgraded to Neutral from Buy at H.C. Wainwright
- 05/06/22 Cantor Fitzgerald
- TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
- 05/06/22 Cantor Fitzgerald
- TherapeuticsMD downgraded to Neutral from Overweight at Cantor Fitzgerald
- 03/11/22 H.C. Wainwright
- TherapeuticsMD price target lowered to $2.50 from $3 at H.C. Wainwright
- 06/07/22 Deutsche Bank
- Deutsche Bank upgrades McKesson to Buy amid recession concerns
- 06/07/22 Deutsche Bank
- McKesson upgraded to Buy from Hold at Deutsche Bank
- 05/11/22 Credit Suisse
- McKesson price target raised to $377 from $333 at Credit Suisse
- 05/10/22 Deutsche Bank
- McKesson price target raised to $343 from $270 at Deutsche Bank
- 04/29/22
- Exxon Mobil reports Q1 adjusted EPS $2.07, consensus $2.12
- 04/28/22
- Notable companies reporting before tomorrow's open
- 02/01/22
- Exxon Mobil reports Q4 ex-items EPS $2.05, consensus $1.93
- 05/16/22
- TherapeuticsMD reports Q1 EPS ($5.69) vs. ($5.67) last year
- 03/10/22
- TherapeuticsMD reports Q4 EPS ex-items (9c), consensus (8c)
- 05/09/22
- Science 37 backs 2022 revenue view $86M-$96M, consensus $91.13M
- 05/09/22
- Science 37 reports Q1 EPS 35c, consensus (22c)
- 03/22/22
- Science 37 sees CY21 revenue $86M-$92M, consensus $104.22M
- 03/22/22
- Science 37 reports Q4 EPS (60c), consensus (21c)
- 04/20/22
- RLI Corp. reports Q1 operating EPS $1.43, consensus 98c
- 01/26/22
- RLI Corp. reports Q4 EPS $1.26, consensus 90c
PRAX Praxis Precision Medicines - 05/09/22
- Praxis Precision Medicines reports Q1 EPS ($1.51), consensus ($1.30)
- 02/28/22
- Praxis Precision Medicines reports Q4 EPS ($1.30), consensus ($1.08)
- 04/27/22
- Plexus reports Q2 EPS 95c, consensus 99c
- 03/07/22
- Plexus reaffirms Q2 EPS guidance 76c-92c, consensus 99c
- 01/26/22
- Plexus sees Q2 EPS 76c-92c, consensus $1.23
- 01/18/22
- Plexus lowers Q1 EPS view 80c-84c from $1.01-$1.07, consensus $1.12
- 05/10/22
- Occidental Petroleum reports Q1 adjusted EPS $2.12, consensus $2.03
- 02/24/22
- Occidental Petroleum reports Q4 adjusted EPS $1.48, consensus $1.10
- 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3.72), consensus ($3.00)
- 02/28/22
- Mirati Therapeutics reports Q4 EPS ($3072), consensus ($3.00)
- 05/05/22
- McKesson sees FY23 adjusted EPS 22.90-$23.60, consensus $23.10
- 05/05/22
- McKesson reports Q4 adjusted EPS $5.83, consensus $6.04
- 02/02/22
- McKesson raises FY22 EPS view to $23.55-$23.95 from $22.35-$22.95
- 02/02/22
- McKesson reports Q3 EPS $6.15, consensus $5.42
- 05/03/22
- Lear cuts FY22 revenue view to $20.4B-$21.2B from $20.8B-$22.3B
- 05/03/22
- Lear reports Q1 adjusted EPS $1.80, consensus $1.57
- 02/08/22
- Lear sees FY22 revenue $20.8B-$22.3B, consensus $22.33B
- 02/08/22
- Lear reports Q4 adjusted EPS $1.22, consensus $1.10
- 05/04/22
- GXO Logistics sees FY22 adjusted EPS $2.70-$2.90, consensus $2.73
- 05/04/22
- GXO Logistics reports Q1 adjusted EPS 59c, consensus 52c
- 02/15/22
- GXO Logistics sees FY22 organic revenue growth of 8% -12%
- 02/15/22
- GXO Logistics reports Q4 EPS 73c, consensus 52c
- 05/06/22
- GrafTech reports Q1 adjusted EPS 48c, consensus 44c
- 02/04/22
- GrafTech reports Q4 adjusted EPS 50c, consensus 42c
- 05/02/22
- Devon Energy reports Q1 EPS $1.88, consensus $1.75
- 02/15/22
- Devon Energy reports Q4 adjusted EPS $1.39, consensus $1.24
- 05/20/22
- Booz Allen sees FY23 adjusted EPS $4.15-$4.45, consensus $4.56
- 05/20/22
- Booz Allen reports Q4 adjusted EPS 86c, consensus 87c
- 05/19/22
- Notable companies reporting before tomorrow's open
- 04/28/22
- Alnylam reports Q1 EPS ($2.00), consensus ($1.84)
- 02/10/22
- Alnylam reports Q4 EPS ($1.69), consensus ($1.54)
- 02/10/22
- Alnylam reports Q4 EPS ($1.69), consensus ($1.54)
- 01/09/22
- Alnylam sees preliminary FY21 combined product revenues $662M
|
Hot Stocks
|
Booz Allen Hamilton… Booz Allen Hamilton announced it was awarded the National Aeronautics and Space Administration, NASA, Cybersecurity and Privacy Enterprise Solutions and Services, CyPrESS, contract-a hybrid indefinite-delivery/indefinite-quantity, IDIQ, single award contract with a total potential value of $622.5M-to provide a complete range of cybersecurity and privacy enterprise solutions and services for NASA's Office of the Chief Information Officer, OCIO. For the first time, this contract brings together all aspects of cybersecurity across the NASA enterprise under one contract to include IT systems, operational technology systems, and mission systems. Work will support all NASA centers and facilities from May 31, 2022 through September 30, 2023, with four option periods running through September 2030. "We're honored that NASA has awarded Booz Allen with the groundbreaking CyPrESS IDIQ contract, which seeks-for the first time-to centralize NASA's cybersecurity posture under one strategic line of work," said Andrea Inserra, executive vice president at Booz Allen Hamilton. "We recognize that NASA's current cyber needs must advance and evolve to protect its more complex missions of the future, and we look forward to building on our long-standing partnership to support NASA's important research, missions, and operations-paving the way to send humans beyond the Moon to Mars-while protecting its people, assets, and information from threats." ShowHide Related Items >><< - 05/20/22
- Booz Allen appoints Kristine Martin Anderson as COO
- 05/20/22
- Booz Allen sees FY23 net cash from operating activities $850M-$950M
- 05/17/22
- Booz Allen awarded $622.5M CyPrESS contract from NASA
- 04/19/22
- Booz Allen makes investment in Reveal Technology
- 06/07/22 Barclays
- Booz Allen downgraded to Equal Weight from Overweight at Barclays
- 05/25/22 Raymond James
- Booz Allen price target raised to $96 from $90 at Raymond James
- 05/18/22 William Blair
- William Blair cautious on Booz Allen shares into Friday's earnings
- 04/13/22 Goldman Sachs
- CACI downgraded to Neutral from Buy at Goldman Sachs
- 05/20/22
- Booz Allen sees FY23 adjusted EPS $4.15-$4.45, consensus $4.56
- 05/20/22
- Booz Allen reports Q4 adjusted EPS 86c, consensus 87c
- 05/19/22
- Notable companies reporting before tomorrow's open
- 05/20/22
- What You Missed On Wall Street On Friday
- 05/20/22
- What You Missed On Wall Street This Morning
- 04/13/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/24/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
|